Back to companies
Organogenesis Holdings Inc.
ORGOUSNASDAQPharmaceuticals & HealthcareOrganogenesis Holdings Inc.
Revenue
$564.2mn
YoY +17.0%
Operating income
$44.7mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API